发明名称 PROPANOIC ACID DERIVATIVES AS INTEGRIN INHIBITORS
摘要 Propanoic acid derivatives of formula (1) are described: Ar-X<1>-Ar<1>-Z-R in which Ar is a nitrogen base containing group; X<1> is linker atom or group; Ar<1> is an optionally substituted 5- or 6-membered nitrogen-containing aromatic or non-aromatic monocycle; Z is a group -CH(R<13>)CH2- [in which R<13> is an optionally substituted aliphatic, cycloaliphatic, heteroaliphatic, heterocycloaliphatic, aromatic or heteroaromatic group], -C(R<12a>)(R<13>)-CH(R<12b>)- [in which R<12a> and R<12b> together with the carbon atoms to which they are attached form a C3-7cycloalkyl group] or C(R<13>)=CH-; R is a carboxylic acid (-CO2H) or a derivative or biostere thereof; and the salts, solvates, hydrates and N-oxides thereof. The compounds are able to inhibit the binding of alpha V integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders.
申请公布号 WO0031067(A1) 申请公布日期 2000.06.02
申请号 WO1999GB03893 申请日期 1999.11.23
申请人 CELLTECH THERAPEUTICS LIMITED;ALEXANDER, RIKKI, PETER;LANGHAM, BARRY, JOHN;REUBERSON, JAMES, THOMAS;TROWN, EMMA, LOUISE;WARRELLOW, GRAHAM, JOHN 发明人 ALEXANDER, RIKKI, PETER;LANGHAM, BARRY, JOHN;REUBERSON, JAMES, THOMAS;TROWN, EMMA, LOUISE;WARRELLOW, GRAHAM, JOHN
分类号 A61K31/505;A61K31/513;A61K31/53;A61K31/55;A61P1/00;A61P1/02;A61P5/18;A61P5/44;A61P7/00;A61P9/00;A61P9/10;A61P17/06;A61P19/02;A61P19/08;A61P19/10;A61P27/02;A61P29/00;A61P35/00;A61P35/04;A61P43/00;C07D239/26;C07D239/34;C07D239/42;C07D401/12;C07D403/12;C07D405/14;C07D521/00;(IPC1-7):C07D401/12 主分类号 A61K31/505
代理机构 代理人
主权项
地址